#2306105858W
Together with our partner Legend Biotech, Janssen NV will develop, manufacture, and commercialize (CAR) T-cell therapy. This partnership is designed to combine the strengths and expertise of two companies to deliver on the promise of a CAR T platform for immunotherapy and investigational treatment.
CAR-T is an innovative blood cancer treatment that uses the strength of the patient's own immune system. The patient's T cells are genetically modified to eliminate the cancer cells. This advanced technology offers hopeful prospects to patients in whom other therapies have no or insufficient results.
Therefore, we are working with great enthusiasm on expanding our capacity for CAR-T treatments in Europe and are fully developing a new production site in Ghent.
As member of the manufacturing excellence team, you will be part of shaping the start-up of the CAR-T production process in Ghent. The process is transferred from the US to Belgium with primary focus on the implementation of the pilot plant in Ghent. You will be part of tech transfer, validation plan, sterilization validation, equipment introduction and technical writing.
Key Responsibilities:
Child care benefits
Paid maternity
Unpaid maternity
Paid paternity
Unpaid paternity
Paid adoptive
Short term disability